Dr. Julia E. Bradsher is the President and CEO of Huntington Medical Research Institutes. She brings to HMRI extensive experience as a successful scientist and strategic leader. Dr. Bradsher directs the organization in its focused growth strategy with the vision of being a leading biomedical research institute within the United States. She heads HMRI’s research, education, community engagement, and fundraising efforts. Before joining HMRI in 2018, her roles included President and CEO of the International Food Protection Training Institute (IFPTI), President and CEO of The Food Allergy & Anaphylaxis Network (FAAN), and leadership and management roles in the pharmaceutical industry. She has occupied faculty and teaching positions at the University of California, San Francisco; Sonoma State University; and San Francisco State University; and she was a research scientist at the New England Research Institute. Her advanced degrees include a PhD in medical sociology from the University of Miami, an MS in gerontology from Baylor University, a BS in psychology from Millsaps College, and an MBA from Suffolk University. She completed the Pew Charitable Trusts Post-Doctoral Fellowship in Health Policy in a joint program at the University of California, San Francisco’s Institute for Health and Aging. Dr. Bradsher has also served on several boards of nonprofit organizations and for-profit companies. She is a Leadership Fellow of the National Association of Corporate Directors (NACD) and an NACD-certified corporate director.

Dr. Robert Kloner has spent more than 40 years running nationally and internationally known cardiovascular research programs – in some cases building them from the ground up – creating centers recognized for scientific excellence and innovation. In addition to his many roles at HMRI, he also serves as Professor of Medicine (Clinical Scholar) at the University of Southern California’s Keck School of Medicine. Bob has made major contributions to science, including the pathophysiology of heart attack; treatments for heart attack; triggers of cardiovascular events; studies on high blood pressure and heart failure; the effect of toxins like alcohol, cocaine, e-cigarette use and pollution on the heart; stem cell therapy for the heart; and the intersection between sexual dysfunction and cardiovascular disease. A frequent contributor to the medical and scientific press, Bob has authored or co-authored over 750 original papers in peer-reviewed journals, 221 chapters or monographs and 538 abstracts (as of 2021).

Mark Dixon joined HMRI in 2019 to develop and maintain our Core Facilities and environmental health and safety (EHS) programs. Mark works with HMRI staff to ensure quality and safety programs are implemented and maintained throughout the organization. He also oversees the operations of HMRI’s Imaging Center and manages the properties. Before joining HMRI, Mark held several research and managerial roles with contract research organizations (CRO), finding a niche in ISO-certified laboratories in highly regulated environments. Mark received both his BS in Nutritional Science and MS in Food Safety from Michigan State University.